IETPPE: Investigations of Ear Tip Performance, Perceptions, and Experiences

Sponsor
University of Arizona (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05725824
Collaborator
(none)
30
1
3
9
3.3

Study Details

Study Description

Brief Summary

Normal hearing participants will be fit with a hearing aid and different types of customized earmolds. Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz. Objective acoustic real ear measures and subjective ratings of sound quality and physical comfort will be evaluated and compared between earmolds. Findings will help researchers to better understand the impacts of different earmolds and how each might affect overall point-of-care.

Condition or Disease Intervention/Treatment Phase
  • Device: BTE hearing aid with compatible earmolds
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Novel Technology Adoption in the Audiology Clinic: Investigations of Ear Tip Performance, Perceptions, and Experiences
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Third-party control

Ear canal impressions will be will be packaged and sent to a professional third-party manufacturer for fabrication in an acrylic material-type. These will serve as the control earmolds, by which the in-house study/intervention earmolds will be compared against. To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).

Device: BTE hearing aid with compatible earmolds
Hearing aids will be fit with three different types of customized earmolds. They will only wear each earmold group for the duration of the test (total = ~2.5 hours). Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz. A short washout period will follow completion of testing with ear earmold group.

Experimental: In-house Study group_Resin

Custom earmold impressions will be scanned and edited using computer-aided design software. These 3D earmold meshes will then be converted to g-code using licensed software and sent to a stereolithography 3D printer for fabrication. Participants will only wear these study earmolds for the duration of testing.To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).

Device: BTE hearing aid with compatible earmolds
Hearing aids will be fit with three different types of customized earmolds. They will only wear each earmold group for the duration of the test (total = ~2.5 hours). Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz. A short washout period will follow completion of testing with ear earmold group.

Experimental: In-house Study group_PLA

Custom earmold impressions will be scanned and edited using computer-aided design software. These 3D earmold meshes will then be converted to g-code using licensed software and sent to a fused deposition modeling 3D printer for fabrication. Participants will only wear these study earmolds for the duration of testing. To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).

Device: BTE hearing aid with compatible earmolds
Hearing aids will be fit with three different types of customized earmolds. They will only wear each earmold group for the duration of the test (total = ~2.5 hours). Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz. A short washout period will follow completion of testing with ear earmold group.

Outcome Measures

Primary Outcome Measures

  1. Real Ear Measures [2nd listening session appointment (~2.5 hours)]

    Evaluation of ear canal acoustics with participant wearing hearing aid and earmold. A thin microphone tube is placed in the ear canal to measure the average amount of sound across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples.

  2. Outer Effectiveness of Auditory Rehabilitation (EAR) questionnaire [2nd listening session appointment (~2.5 hours)]

    A questionnaire eliciting patient perception of physical comfort, quality of voice, and overall self-perceived satisfaction. Includes 12 items (5 point) that are scored on a 0 to 100, with 100 representing best possible function/rating

  3. Speech Spatial Qualities (SSQ) questionnaire: [2nd listening session appointment (~2.5 hours)]

    A subsection of this questionnaire, " qualities of hearing", will be administered to evaluate participant's perceptions of acoustic quality and comfort. This subsection includes 18 items (10 points) that are scored on a 0 to 10, with 10 representing best possible function/rating

Secondary Outcome Measures

  1. Physical variables [Prior to 2nd listening session appointment (~7-14 days)]

    Physical dimensions of earmolds will be taken using digital calipers. Does not require participants to be present.

  2. Production variables [Prior to 2nd listening session appointment (~7-14 days)]

    The total raw cost ($) and time (min) of production will be measured for each earmold group.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Normal hearing thresholds (<25 dB HL) at octave frequencies from 250-8000Hz.

  • Normal otoscopy: patent ear canals with normal appearing eardrums and aerated middle ear, bilaterally.

  • English as primary spoken language.

Exclusion Criteria:
  • history of extensive or current outer or middle ear pathology.

  • history of extensive outer or middle ear surgery.

  • history of neurological or cognitive disorder.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Arizona Tucson Arizona United States 85721

Sponsors and Collaborators

  • University of Arizona

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Arizona
ClinicalTrials.gov Identifier:
NCT05725824
Other Study ID Numbers:
  • STUDY00002336
First Posted:
Feb 13, 2023
Last Update Posted:
Feb 13, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by University of Arizona

Study Results

No Results Posted as of Feb 13, 2023